메뉴 건너뛰기




Volumn 4, Issue 1, 2004, Pages 54-56

Gene therapy trials in the UK: Is haemophilia a suitable 'model'?

Author keywords

Adverse events; Ethics; Gene therapy; Haemophilia; Legislation

Indexed keywords

ADENOVIRUS VECTOR; ORNITHINE CARBAMOYLTRANSFERASE;

EID: 1342290697     PISSN: 14702118     EISSN: None     Source Type: Journal    
DOI: 10.7861/clinmedicine.4-1-54     Document Type: Review
Times cited : (2)

References (10)
  • 1
    • 0035676918 scopus 로고    scopus 로고
    • Gene therapy for haemophilia
    • Pasi KJ. Gene therapy for haemophilia. Br J Haematol 2001;115:744-57.
    • (2001) Br J Haematol , vol.115 , pp. 744-757
    • Pasi, K.J.1
  • 3
    • 0033579358 scopus 로고    scopus 로고
    • Gene therapy death prompts review of adenovirus vector
    • Marshall E. Gene therapy death prompts review of adenovirus vector. Science 1999;286:2244-5.
    • (1999) Science , vol.286 , pp. 2244-2245
    • Marshall, E.1
  • 4
    • 0037448352 scopus 로고    scopus 로고
    • A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency
    • Hacein-Bey-Abina S, von Kalle C, Schmidt M, Le Deist F et al. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 2003;348:255-6.
    • (2003) N Engl J Med , vol.348 , pp. 255-256
    • Hacein-Bey-Abina, S.1    Von Kalle, C.2    Schmidt, M.3    Le Deist, F.4
  • 5
    • 0034923893 scopus 로고    scopus 로고
    • Gene therapy in hemophilia: Clinical trials update
    • White GC, 2nd. Gene therapy in hemophilia: clinical trials update. Thromb Haemost 2001;86(1):172-7.
    • (2001) Thromb Haemost , vol.86 , Issue.1 , pp. 172-177
    • White II, G.C.1
  • 6
    • 0035822005 scopus 로고    scopus 로고
    • Nonviral transfer of the gene encoding coagulation factor VIII in patients with severe hemophilia A
    • Roth DA, Tawa NE, Jr, O'Brien JM, Treco DA, Selden RF. Nonviral transfer of the gene encoding coagulation factor VIII in patients with severe hemophilia A. N Engl J Med 2001;344(23):1735-42.
    • (2001) N Engl J Med , vol.344 , Issue.23 , pp. 1735-1742
    • Roth, D.A.1    Tawa Jr., N.E.2    O'Brien, J.M.3    Treco, D.A.4    Selden, R.F.5
  • 7
    • 0034050904 scopus 로고    scopus 로고
    • Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector
    • Kay MA, Manno CS, Ragni MV, Larson PJ, Couto LB et al. Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector. Nat Genet 2000;24(3):257-61.
    • (2000) Nat Genet , vol.24 , Issue.3 , pp. 257-261
    • Kay, M.A.1    Manno, C.S.2    Ragni, M.V.3    Larson, P.J.4    Couto, L.B.5
  • 8
    • 0012573980 scopus 로고    scopus 로고
    • A phase I/II clinical trial for liver directed AAV-mediated gene transfer for severe hemophilia B
    • Abstract
    • MA Kay, K High, B Glader, C Manno, S Hutchinson et al. A phase I/II clinical trial for liver directed AAV-mediated gene transfer for severe hemophilia B. Blood 2002;100:115a (Abstract).
    • (2002) Blood , vol.100
    • Kay, M.A.1    High, K.2    Glader, B.3    Manno, C.4    Hutchinson, S.5
  • 9
    • 0141679053 scopus 로고    scopus 로고
    • Phase I trial of FVIII gene transfer for severe hemophilia A using a retroviral construct administered by peripheral intravenous injection
    • Powell JS, Ragni MV, White GC, Lusher J et al. Phase I trial of FVIII gene transfer for severe hemophilia A using a retroviral construct administered by peripheral intravenous injection. Blood 2003;102:2038-45.
    • (2003) Blood , vol.102 , pp. 2038-2045
    • Powell, J.S.1    Ragni, M.V.2    White, G.C.3    Lusher, J.4
  • 10
    • 1342307259 scopus 로고    scopus 로고
    • www.doh.gov.uk/genetics/gtac.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.